During the past decade, West Virginia University CTRU conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "West Virginia University CTRU" #1 collaborator was "Ortho Biotech, Inc." with 1 trials as a collaborator and "Tragara Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "West Virginia University CTRU" are "Multiple Myeloma" (2 trials), "Breast Cancer" (1 trials), "Colon Cancer" (1 trials), "Isocitrate Dehydrogenase" (1 trials) and "Leukemia, Myeloid" (1 trials). Many other conditions were trialed in "West Virginia University CTRU" in a lesser frequency.

Most popular intervention types in "West Virginia University CTRU" are "Drug" (5 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "AG-221" (1 trials), "Abraxane" (1 trials), "Azacitidine" (1 trials), "BSC" (1 trials) and "Bortezomib" (1 trials). Other intervention names were less common.

The vast majority of trials in "West Virginia University CTRU" are 6 trials for "All" genders.

Currently, there are NaN active trials in "West Virginia University CTRU". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in West Virginia University CTRU, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in West Virginia University CTRU, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".